Gout can affect the eyes in several ways, from persistent dryness and redness to visible crystal deposits on or around the eye. The same urate crystals responsible for painful joint flares can settle in ocular tissues including the eyelids, the white of the eye, the cornea, and even the retina. While these eye complications are uncommon compared with joint disease, they are more varied and consequential than most people with gout realize.
Why Gout Does Not Stay in the Joints
Gout develops when the body accumulates too much uric acid, which forms needle-shaped monosodium urate (MSU) crystals. Most people associate those crystals with swollen, excruciatingly painful joints, especially the big toe. But uric acid circulates through the bloodstream, meaning crystals can theoretically settle wherever blood reaches. In and around the eye, case reports and reviews have documented tophaceous deposits in the eyelids, the conjunctiva (the clear membrane over the white of the eye), the cornea, the iris, the sclera, and the orbit.1PubMed. Beyond Joints: a Review of Ocular Abnormalities in Gout and Hyperuricemia Crystal deposition is only one pathway, though. The chronic, low-grade inflammation that accompanies years of elevated uric acid creates an environment that can damage delicate eye structures even without visible crystal deposits.
Dry Eye Disease
The most widely studied eye problem linked to gout is dry eye disease. If you have gout and your eyes frequently feel gritty, burn, or water excessively, that may not be a coincidence. A large population-based cohort study found that people with gout had a higher rate of developing dry eye compared with matched controls, and that the risk grew with longer disease duration.2PubMed Central. Gout as a Risk Factor for Dry Eye Disease: A Population-Based Cohort Study Two other population studies, both examining older adults, independently identified a history of gout as a significant risk factor for dry eye symptoms after adjusting for age and sex.3JAMA Ophthalmology. Prevalence of and Risk Factors for Dry Eye Syndrome4PubMed. Prevalence and associations of dry eye syndrome in an older population: the Blue Mountains Eye Study
Why would gout dry out your eyes? The mechanism is not fully pinned down, but inflammation is the strongest candidate. Chronic systemic inflammation can disrupt the tear film’s delicate balance of oil, water, and mucus. Urate crystals deposited in the conjunctiva may also irritate the ocular surface directly, reducing tear quality even when tear volume is adequate. Many gout patients also take diuretics for coexisting high blood pressure or kidney issues, and diuretics are themselves a known contributor to dry eye. Sorting out which factor matters most in any individual is tricky, but the association between gout and dry eye is consistent across studies. Eye dryness in gout patients often goes unrecognized as connected to the disease, yet catching it early can make a real difference in comfort and long-term eye health.5PubMed Central. Correlation between gout and dry eye disease
Red Eyes, Scleritis, and Conjunctival Changes
Chronic, recurring red eyes are one of the more recognizable eye symptoms tied to gout flares. The redness can come from inflammation of the sclera (the white outer coat of the eye), the episclera (the thin tissue overlying it), or the iris. Scleritis and episcleritis cause a deep, aching redness that is different from the superficial bloodshot look of allergies or fatigue. Iritis, inflammation of the colored part of the eye, can cause light sensitivity, pain, and blurred vision. All three have been reported in association with acute gouty attacks.6Clinical Eye and Vision Care. Ocular and systemic manifestations of gout
Beyond inflammation, the conjunctiva itself can show physical signs of urate crystal activity. A study comparing gout patients at different disease stages with healthy controls found that dilated, tortuous blood vessels on the conjunctiva and scleral surface were significantly more common in people with active or advanced gout than in controls. The same study observed transparent, shiny vesicles beneath the conjunctiva in roughly a third of patients with active gout, compared with only about four percent of healthy subjects.7PubMed Central. Characteristics of ocular abnormalities in gout patients Those vesicles are thought to represent tiny collections of urate crystals just beneath the surface. Conjunctival redness and subconjunctival bleeding can also flare up after eating purine-rich foods, a pattern that may go unrecognized if neither the patient nor the doctor connects the eye redness to dietary triggers.8Clinical & Experimental Ophthalmology. Review of the ophthalmic manifestations of gout and uric acid crystal deposition
Crystal Deposits on and Around the Eye
When gout goes untreated or is poorly controlled over many years, it can form tophi, which are chalky nodules of crystallized urate surrounded by inflammatory tissue. Most tophi show up in the toes, fingers, elbows, or ears. On rare occasions, they appear around the eyes. One well-documented case involved a man with a 15-year history of gout who developed a painless, hard, yellowish lump on his upper eyelid that slowly grew over two years. A biopsy revealed the classic needle-shaped urate crystals surrounded by a granulomatous reaction, confirming it as a gouty tophus.9PubMed Central. A Case of Gouty Tophus of the Left Upper Eyelid These eyelid tophi can mimic tumors or cysts, leading to unnecessary concern until the underlying gout is identified. Similar deposits have been documented on the conjunctiva, sclera, and even within the orbit.1PubMed. Beyond Joints: a Review of Ocular Abnormalities in Gout and Hyperuricemia
The cornea can also be involved. Band keratopathy is a condition where calcium or other crystite deposits form a horizontal, band-like opacity across the central cornea, right in the line of sight. It has multiple causes, including chronic eye inflammation and elevated calcium, and gout is among them. Crystal deposition in the front layers of the cornea can gradually cloud vision if it advances to cover the visual axis.10CRO (Clinical & Refractive Optometry) Journal. Atypical Gout-Associated Band Keratopathy While uncommon, band keratopathy from gout is important because it can be mistaken for other corneal diseases and because treatment involves managing the underlying uric acid level, not just treating the eye locally.
Effects Deeper in the Eye
Urate crystals have been found deeper inside the eye as well. In one reported case, a patient with chronically uncontrolled gout was found to have highly refractile, crystal-like lesions in the macula, the part of the retina responsible for sharp central vision. The crystals appeared at the ends of tiny retinal arterioles and sat at the level of the retinal pigment epithelium.11PubMed Central. Retinal complications of gout: a case report and review of the literature Crystal deposits in the retina could interfere with blood flow or trigger local inflammation, both of which threaten vision. These findings are rare and mostly come from case reports, but they illustrate just how far urate crystal deposition can reach when gout is left unchecked.
There is also a growing body of research exploring whether elevated uric acid contributes to age-related macular degeneration (AMD), one of the leading causes of vision loss in older adults. AMD involves damage to the macula, and its progression is driven partly by inflammation and oxidative stress. A review of the emerging evidence describes a potential link between high serum uric acid levels and the formation of abnormal new blood vessels in the retina, a hallmark of advanced AMD. Several pathways have been proposed, including both crystal-related and non-crystal-related inflammation, though researchers emphasize that more work is needed to clarify the exact molecular interactions.12FASEB Journal. Current updates for hyperuricemia and gout in age-related macular degeneration This is an area where the science is still early, so it is too soon to say that gout causes AMD. But the shared inflammatory pathways make the connection biologically plausible and worth watching.
The Inflammation Pathway That Connects Gout to Cataracts
One of the more surprising connections in this field involves the lens of the eye. A 2024 laboratory study demonstrated that uric acid at elevated concentrations can trigger inflammation inside the lens itself, leading to clouding. The key mechanism involves the NLRP3 inflammasome, an immune signaling complex that the body activates in response to danger signals like urate crystals. In rat lenses treated with high concentrations of uric acid, researchers observed a dramatic increase in NLRP3 activation and downstream inflammatory markers. This inflammatory cascade appeared to precede visible lens clouding, suggesting that the inflammation comes first and the cataract follows.13Cell Death Discovery. Uric acid–driven NLRP3 inflammasome activation triggers lens epithelial cell senescence and cataract formation
This same NLRP3 inflammasome pathway is already well established in gout’s joint inflammation, so the finding that it also operates in the eye’s lens is a meaningful piece of the puzzle. It suggests that the systemic inflammatory state driven by high uric acid does not spare ocular tissues simply because they lack a joint capsule. The lens, like cartilage, is avascular and depends on the fluid around it for nourishment, which may make it vulnerable to circulating inflammatory signals and urate-driven damage.
Allopurinol and Cataract Risk
Here is a frustrating irony for gout patients: one of the most commonly prescribed gout medications may itself contribute to cataract development. Allopurinol, a urate-lowering drug that millions of gout patients take long-term, has been linked to lens changes since the early 1980s, when the National Registry of Drug-Induced Ocular Side Effects accumulated 30 cases of suspected allopurinol-related cataracts. The reported pattern starts with changes to the front and back surfaces of the lens capsule, progressing over time to wedge-shaped cortical haze and dense posterior subcapsular cataracts.14PubMed. Cataracts associated with allopurinol therapy
A later study examined the relationship more rigorously in elderly patients and found that cumulative allopurinol doses above 400 grams, or continuous use for longer than three years, were associated with a meaningfully increased risk of needing cataract surgery. Shorter durations and lower cumulative doses did not show an elevated risk.15Archives of Ophthalmology. Exposure to Allopurinol and the Risk of Cataract Extraction in Elderly Patients This does not mean everyone on allopurinol will develop cataracts, and the benefit of controlling uric acid levels typically outweighs this risk. But it does mean that long-term allopurinol users should be aware that periodic eye exams are worth their time, and that any lens changes should be discussed with both the eye doctor and the prescribing rheumatologist.
The tricky part is separating the effect of the drug from the effect of the disease. As the inflammasome research described above suggests, chronically high uric acid can damage the lens on its own. So a gout patient who develops cataracts may be experiencing a drug side effect, a disease complication, or both simultaneously. Clinicians tend to weigh this by looking at the cumulative dose and duration of allopurinol therapy alongside how well-controlled the patient’s uric acid has been over the years.
Why These Eye Problems Often Go Unrecognized
Most rheumatologists and primary care doctors focus, understandably, on joints and kidneys when managing gout. Eye involvement is not part of the standard conversation at a gout follow-up visit. On the flip side, ophthalmologists who see a patient with scleritis or unexplained dry eye may not think to ask about gout history. The result is a recognition gap. Conjunctival redness that worsens after a steak dinner, persistent dry eye in a patient with years of elevated uric acid, or a yellowish eyelid bump in someone who already has joint tophi may all be connected to gout but are rarely identified as such.
One comprehensive review of the literature noted that while conjunctival redness and subconjunctival bleeding linked to purine intake are among the more common eye manifestations, they frequently go unrecognized. The same review cautioned that ocular manifestations of gout are genuinely rare and may have been over-reported in older medical literature, so it would be wrong to assume every eye complaint in a gout patient stems from the disease.8Clinical & Experimental Ophthalmology. Review of the ophthalmic manifestations of gout and uric acid crystal deposition Striking the right balance matters: not every red eye is gout-related, but dismissing all eye symptoms as unrelated is also a mistake, especially in patients with long-standing or poorly controlled disease.
What to Watch for and When to Speak Up
If you have gout, certain eye symptoms warrant mentioning to your doctor rather than chalking them up to allergies or aging:
- Persistent dryness: gritty, burning, or chronically watering eyes that do not respond well to over-the-counter drops, especially if the symptoms worsened after your gout diagnosis or during flare periods.
- Recurring redness: a deep red or purple-red hue in the white of the eye that comes and goes, particularly if it coincides with joint flares or heavy meals.
- Eye pain with light sensitivity: these suggest iritis or scleritis rather than simple irritation, and both conditions need prompt treatment to prevent lasting damage.
- A painless lump on the eyelid: slow-growing, firm, and yellowish, it could be a tophus and deserves a biopsy rather than watchful waiting.
- Gradual vision clouding: especially if you have been on allopurinol for several years, report any haziness or glare sensitivity at your next eye exam.
Routine eye exams become more important when you have a systemic inflammatory disease. Letting your eye doctor know about your gout diagnosis, your medication list, and your most recent uric acid level gives them context to spot problems that might otherwise go unexplained. And if an ophthalmologist discovers urate-like deposits on a slit-lamp exam, that information can loop back to the rheumatologist as a sign that uric acid control needs tightening.
Imaging and Diagnosis of Ocular Urate Deposits
When an eye doctor suspects urate crystal deposits in or around the eye, confirming the diagnosis can require more than a standard exam. Tophi near the surface, like those on the eyelid or conjunctiva, can often be biopsied and examined under polarized-light microscopy, which reveals the characteristic needle-shaped, negatively birefringent crystals that define gout. For deeper or less accessible deposits, imaging plays a growing role. Conventional X-rays are not very useful for soft-tissue deposits around the eye, but ultrasound, CT, and MRI can detect tophi and erosions that plain films miss.16Seminars in Arthritis and Rheumatism. The Broad Spectrum of Urate Crystal Deposition: Unusual Presentations of Gouty Tophi In the retina, crystal deposits are typically identified during a dilated fundus examination as bright, reflective spots, sometimes confirmed with optical coherence tomography (OCT), a non-invasive scan that produces cross-sectional images of retinal layers.11PubMed Central. Retinal complications of gout: a case report and review of the literature
The challenge with diagnosing ocular gout is that many of its manifestations mimic other conditions. Band keratopathy can look identical whether it is caused by gout, chronic uveitis, or elevated calcium. A scleral nodule could be a tophus or a completely unrelated growth. A subconjunctival hemorrhage is common and usually benign. Context matters enormously: a confirmed gout diagnosis, elevated uric acid levels, and a history of poor disease control all shift the probability toward gout being the culprit. Without that context, eye findings alone rarely lead a clinician to gout as the explanation.